Brand Name: Pomalyst
Generic Name: pomalidomide
Drug Class: Antineoplastics, Angiogenesis Inhibitors
What is Pomalyst (pomalidomide), and what is it used for?
Pomalyst is a prescription medicine used to treat adults with:
- Multiple myeloma. Pomalyst is taken along with the medicine dexamethasone, in people who:
- AIDS-related Kaposi sarcoma (KS). Pomalyst is taken when highly active antiretroviral therapy (HAART) has not worked well enough or stopped working (failed)
- KS who do not have HIV infection (HIV negative).
It is not known if Pomalyst is safe and effective in children.
Who should not take Pomalyst?
Do not take Pomalyst if you:
- are pregnant, plan to become pregnant, or become pregnant during treatment with Pomalyst.
- are allergic to pomalidomide or any of the ingredients in Pomalyst.
- Pomalyst is contraindicated in pregnancy. Pomalyst is a thalidomide analogue. Thalidomide is a known human teratogen that causes severe birth defects or embryo-fetal death. In females of reproductive potential, obtain 2 negative pregnancy tests before starting Pomalyst treatment.
- Females of reproductive potential must use 2 forms of contraception or continuously abstain from heterosexual sex during and for 4 weeks after stopping Pomalyst treatment.
Pomalyst is only available through a restricted distribution program called Pomalyst REMS.
Venous and Arterial Thromboembolism
- Deep venous thrombosis (DVT), pulmonary embolism (PE), myocardial infarction, and stroke occur in patients with multiple myeloma treated with Pomalyst. Prophylactic antithrombotic measures were employed in clinical trials. Thromboprophylaxis is recommended, and the choice of regimen should be based on assessment of the patient's underlying risk factors.
What are the side effects of Pomalyst?
Pomalyst can cause serious side effects, including:
- Low white blood cells (neutropenia), low platelets (thrombocytopenia), and low red blood cells (anemia) are common with Pomalyst, but can also be serious. You may need a blood transfusion or certain medicines if your blood counts drop too low. Your blood counts should be checked weekly for the first 8 weeks of treatment and monthly after that.
- Severe liver problems, including liver failure and death. Your healthcare provider should do blood tests to check your liver function during your treatment with Pomalyst. Tell your healthcare provider right away if you develop any of the following symptoms of liver problems:
- Severe allergic reactions and severe skin reactions can happen with Pomalyst and may cause death.
Call your healthcare provider if you develop any of the following signs or symptoms during treatment with Pomalyst:
Get emergency medical help right away if you develop any of the following signs or symptoms during treatment with Pomalyst:
- Dizziness and confusion.
- Nerve damage. Stop taking Pomalyst and call your healthcare provider if you develop symptoms of nerve damage including: numbness, tingling, pain, burning sensation in your hands, legs, or feet.
- Risk of new cancers (malignancies). New cancers, including certain blood cancers (acute myelogenous leukemia or AML) have been seen in people who received Pomalyst. Talk with your healthcare provider about your risk of developing new cancers if you take Pomalyst.
- Tumor lysis syndrome (TLS). TLS is caused by the fast breakdown of cancer cells. TLS can cause kidney failure and the need for dialysis treatment, abnormal heart rhythm, seizure, and sometimes death. Your healthcare provider may do blood tests to check you for TLS.
Your healthcare provider may tell you to stop taking Pomalyst if you develop certain serious side effects during treatment.
The most common side effects of Pomalyst in people with Multiple Myeloma include:
- tiredness and weakness
- shortness of breath
- upper respiratory tract infection
- back pain
The most common side effects of Pomalyst in people with KS include:
- abnormal kidney function tests
- decreased phosphate and calcium in the blood
- rash. See “Severe allergic reactions and severe skin reactions” above.
- increased blood sugar
- decreased albumin in the blood
These are not all the possible side effects of Pomalyst.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is the dosage for Pomalyst?
Pregnancy Testing Prior to Administration
- Females of reproductive potential must have negative pregnancy testing and use contraception methods before initiating Pomalyst.
Recommended Dosage for Multiple Myeloma
- The recommended dosage of Pomalyst is 4 mg once daily orally with or without food on Days 1 through 21 of each 28-day cycle until disease progression. Give Pomalyst in combination with dexamethasone.
Recommended Dosage for Kaposi Sarcoma
- The recommended dosage of Pomalyst is 5 mg once daily taken orally with or without food on Days 1 through 21 of each 28-day cycle until disease progression or unacceptable toxicity. Continue HAART as HIV treatment in patients with AIDS-related Kaposi sarcoma (KS).
Dosage Modifications for Hematologic Adverse Reactions
Multiple Myeloma: Dosage Modifications For Hematologic Adverse Reactions
- Initiate a new cycle of Pomalyst in patients with multiple myeloma (MM) when the neutrophil count is at least 500 per mcL and the platelet count is at least 50,000 per mcL.
- Dosage modification for Pomalyst for hematologic adverse reactions in patients with MM are summarized in Table 1.
Table 1: Dosage Modifications for Pomalyst for Hematologic in MM
|Adverse Reaction||Severity||Dosage Modification|
|* Permanently discontinue Pomalyst if unable to tolerate 1 mg once daily.
ANC= absolute neutrophil count
Kaposi Sarcoma: Dosage Modifications for Hematologic Adverse Reactions
- Initiate a new cycle of Pomalyst in patients with KS when the neutrophil count is at least 1000 per mcL and the platelet count is at least 75,000 per mcL.
- Dose modifications for Pomalyst for hematologic adverse reactions in patients with KS are summarized in Table 2.
Table 2: Dosage Modifications for Pomalyst for Hematologic Adverse Reactions in KS
|Adverse Reaction||Severity||Dosage Modification|
|Neutropenia||ANC 500 to less than 1,000 per mcL||Day 1 of cycle
|ANC less than 500 per mcL||
|Febrile Neutropenia||ANC less than 1,000 per mcL and single temperature greater than or equal to 38.3°C or ANC less than 1,000 per mcL and sustained temperature greater than or equal to 38C for more than 1 hour||
|Thrombocytopenia||Platelet count 25,000 to less than 50,000 per mcL||Day 1 of cycle
|Platelet count less than 25,000 per mcL||Permanently discontinue Pomalyst.|
|* Permanently discontinue Pomalyst if unable to tolerate 1mg once daily.
ANC= absolute neutrophil count
Dosage Modifications for Non-Hematologic Adverse Reactions
- Permanently discontinue Pomalyst for angioedema, anaphylaxis, Grade 4 rash, skin exfoliation, bullae, or any other severe dermatologic reaction.
- For other Grade 3 or 4 toxicities, hold treatment and restart treatment at 1 mg less than the previous dose when toxicity has resolved to less than or equal to Grade 2 at the physicianâ€™s discretion.
Dosage Modifications for Strong CYP1A2 Inhibitors
- Avoid concomitant use of Pomalyst with strong CYP1A2 inhibitors. If concomitant use of a strong CYP1A2 inhibitor is unavoidable, reduce Pomalyst dose to 2 mg.
Dosage Modification for Severe Renal Impairment on Hemodialysis
Take Pomalyst after completion of dialysis procedure on hemodialysis days.
- For patients with MM with severe renal impairment requiring dialysis, reduce the recommended dosage to 3 mg orally daily.
- For patients with KS with severe renal impairment requiring dialysis, reduce the recommended dosage to 4 mg orally daily.
Dosage Modification for Hepatic Impairment
- For patients with MM with mild or moderate hepatic impairment (Child-Pugh A or B), reduce the recommended dosage to 3 mg orally daily.
- For patients with MM with severe hepatic impairment (Child-Pugh C), reduce the recommended dosage to 2 mg.
- For patients with KS with mild, moderate, or severe hepatic impairment (Child-Pugh A, B, or C), reduce the recommended dosage to 3 mg orally daily.
- Swallow capsules whole with water. Do not break, chew, or open the capsules. Pomalyst may be taken with or without food.
- After Salmonella Cases Double in a Week, Cantaloupe Recall Expanded
- Soccer 'Heading' Tied to Declines in Brain Function
- Smoking Tobacco Plus Weed Greatly Raises Odds for Emphysema
- COVID Vaccines Curbed Pandemic-Linked Surge in Preemie Births
- Could a 'Brain Coach' Help Folks at Higher Risk for Alzheimer's?
- More Health News »
What drugs interact with Pomalyst?
Drugs That Affect Pomalidomide Plasma Concentrations
- In healthy subjects, co-administration of fluvoxamine, a strong CYP1A2 inhibitor, increased Cmax and AUC of pomalidomide by 24% and 125% respectively.
- Increased pomalidomide exposure may increase the risk of exposure related toxicities.
- Avoid co-administration of strong CYP1A2 inhibitors (e.g. ciprofloxacin and fluvoxamine). If co-administration is unavoidable, reduce the Pomalyst dose.
Pregnancy and breastfeeding
- Based on the mechanism of action and findings from animal studies, Pomalyst can cause embryo-fetal harm when administered to a pregnant female and is contraindicated during pregnancy.
- There is a pregnancy exposure registry that monitors pregnancy outcomes in females exposed to Pomalyst during pregnancy as well as female partners of male patients who are exposed to Pomalyst. This registry is also used to understand the root cause for the pregnancy. Report any suspected fetal exposure to Pomalyst to the FDA via the MedWatch program at 1-800-FDA-1088 and also to Celgene Corporation at 1-888-4235436.
- There is no information regarding the presence of pomalidomide in human milk, the effects of Pomalyst on the breastfed child, or the effects of Pomalyst on milk production.
- Because many drugs are excreted in human milk and because of the potential for adverse reactions in a breastfed child from Pomalyst, women should not breastfeed during treatment with Pomalyst.
Pomalyst is a prescription medicine used to treat adults with multiple myeloma, AIDS-related Kaposi sarcoma (KS), and non-AIDS-related Kaposi sarcoma (KS). Serious side effects include severe birth defects and miscarriage when taken in pregnancy, venous and arterial thromboembolism, low white blood cells (neutropenia), low platelets (thrombocytopenia), low red blood cells (anemia), severe liver problems, and Severe allergic reactions and severe skin reactions.
Multimedia: Slideshows, Images & Quizzes
Understanding Cancer: Metastasis, Stages of Cancer, and More
Learn the basics about cancer including types, causes, how it spreads, symptoms and signs, stages and treatment options. Read...
Cancer-Fighting Foods: Resveratrol, Green Tea, and More
Experts have praised certain foods for their ability to reduce cancer risks. Learn which foods and eating strategies may help...
Signs of Cancer in Women: Symptoms You Can't Ignore
Colon and stomach cancer symptoms can surprise women but can be treated if detected early. Learn about breast cancer signs and...
Top 10 Cancers Quiz
Take this quiz to learn the causes of cancer. Get the facts about the causes, symptoms, and treatments for the world's most...
Multiple Myeloma Quiz
Multiple myeloma is a form of cancer. Take this quiz common signs and symptoms of multiple myeloma and who is at risk.
Cancer: Guide to Leukemia
Learn about the common types and stages of leukemia, who gets it, symptoms, tests, treatments, and more. People with blood cancer...
Cancer: How to Lower and Cut Your Risk of Cancer
About a third of all cases of cancer can be prevented. Find out how to lower your chances of getting it.
Cancer: Symptoms of Common Cancers in Men
Can men get breast cancer? Cancer symptoms men need to watch out for include skin changes, difficulty swallowing, rapid weight...
Cancer: Cancer 'Remedies' That Don't Work
You may have read about an all-natural cure for cancer. While many therapies are helpful, some aren't worth your time or money....
Cancer Guide to Eye Cancers
Find out more from WebMD about the early signs of these types of cancer and how they’re diagnosed and treated.
Related Disease Conditions
Cancer Risk Factors and Causes
Though it's difficult to say why some people develop cancer while others don't, research shows that certain risk factors increase a person's odds of developing cancer. These risk factors include growing older, family history of cancer, diet, alcohol and tobacco use, and exposure to sunlight, ionizing radiation, certain chemicals, and some viruses and bacteria.
Multiple myeloma is a form of cancer that develops in plasma cells, the white blood cells that make antibodies. Symptoms include bone pain, weakness, extreme thirst, nausea, frequent urination, and broken bones. Treatment of multiple myeloma depends upon the staging and symptoms of the disease.
Multiple Myeloma: Deadly to Chronic
Multiple myeloma is cancer of the plasma cells. The plasma cells are a type of white blood cell present in the bone marrow. Plasma cells are part of the immune system and help fight against infections by producing antibodies that recognize and attack microorganisms. In multiple myeloma, cancer cells accumulate in the bone marrow and replace healthy blood cells.
At What Stage of Cancer is Chemotherapy Used?
The decision to use chemotherapy may vary depending on the aggressiveness, stage and type of cancer. Usually, chemotherapy may be used for all stages in most cancer types. Chemotherapy is a type of medicine or combination of medications that is used to treat or kill cancer cells.
Is Multiple Myeloma Genetic or Hereditary?
Multiple myeloma is a cancer of the white blood cells, also called plasma cells. Multiple myeloma is linked to specific gene mutations.
AIDS (Acquired Immunodeficiency Syndrome)
AIDS is the advanced stage of HIV infection. Symptoms and signs of AIDS include pneumonia due to Pneumocystis jiroveci, tuberculosis, toxoplasmosis, seizures, weakness, meningitis, yeast infection of the esophagus, and Kaposi's sarcoma. Anti-retroviral therapy (HAART) is used in the treatment of AIDS.
Cancer pain is a common experience that may result from the disease, treatment, or diagnostic procedure. Check out the center below for more medical references on cancer, including multimedia (slideshows, images, and quizzes), related disease conditions, treatment and diagnosis, medications, and prevention or wellness.
Multiple Myeloma: Types of Treatment
Multiple myeloma is a cancer of the plasma cells. The plasma cells are a type of white blood cell present in the bone marrow. Plasma cells are part of the immune system and help fight against infections by producing antibodies that recognize and attack microorganisms.
What Causes Kaposi Sarcoma?
Kaposi sarcoma (KS) is a form of cancer caused by herpesvirus infection. This virus is known as Kaposi sarcoma-associated herpesvirus (KSHV) or human herpesvirus 8 (HHV-8). Causes of Kaposi sarcoma include immune suppression, HIV infection and certain socioeconomic factors.
Treatment & Diagnosis
- Cancer FAQs
- Multiple Myeloma FAQs
- Generic AIDS Drug Effective - And Now?
- Is Multiple Myeloma the Same as Leukemia?
- How Common Is Multiple Myeloma?
- Is Multiple Myeloma Curable?
- How Many Stages of Multiple Myeloma Are There?
- What Is the Life Expectancy of Someone with Multiple Myeloma?
- 10 Cancer Symptoms That Men Ignore
Medications & Supplements
Health Solutions From Our Sponsors
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.